ORLAAM

Active Ingredient(s): Levomethadyl
FDA Approved: * July 9, 1993
Pharm Company: * ROXANE
Category: Opioid Dependence

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



ORLAAM Overview

Levacetylmethadol (INN), levomethadyl acetate (USAN), OrLAAM (trade name) or levo-α-acetylmethadol (LAAM)[1][2] is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites. It was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, levacetylmethadol was removed from the European market due to reports of life-threatening ventricular rhyt...

Read more ORLAAM Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Levacetylmethadol

Recent ORLAAM Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Levomethadyl
  • Concentrate: 10mg/ml
  • Liquid: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Levomethadyl or a similar ingredient: (1 result)

Related ORLAAM Topics:

orlaam
tolerane of orlaam...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA